Journal of Hematology Oncology Pharmacy

Featured Articles

Facial Edema Preceding Acute Renal Injury Linked to Pemetrexed Therapy in a Patient with Lung Cancer

Matthew S. Mattila, PharmD, BCPS, BCOP, Joel M. Lundberg, MD, FACP

Assessment of High-Dose Methotrexate Management Guideline in Adults with Cancer at an Academic Medical Center

Andrew Kowalski, PharmD, BCOP, Sara Mohamed Jaszczur, PharmD, BCOP, Michelle Nadeau-Nguyen, PharmD, BCPS, Man-Yee Merl, PharmD, BCOP

Comparison of Direct Oral Factor Xa Inhibitors versus Warfarin for the Treatment of Venous Thromboembolism in Obese or Overweight Patients: A Retrospective Analysis

Jennifer C. Cook, PharmD, Tracy E. Wiczer, BCOP, PharmD, Anthony T. Gerlach, PharmD, FCCM, FCCP, Caitli Linger, PharmD, Meghan E. Ritchey, PharmD Candidate, Bridgette M. Zickefoose, PharmD, Tzu-Fei Wang, MD, Kristin I. Brower, BCPS, PharmD

Biomarker-Driven Targeted Therapies in Solid Tumor Malignancies

Hanjie Mo, PharmD, BCOP, Catherine Renna, PharmD, BCOP

Overcoming Resistance: Antibiotic Guidance for Multidrug-Resistant Febrile Neutropenia in Patients with Cancer

Sonya K. Kedzior, PharmD, YoungYoon Ham, PharmD, Joseph Bubalo, PharmD, BCPS, BCOP

From the Literature

Oral Azacitidine Prolongs Survival in Patients with Acute Myeloid Leukemia

Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA

Enfortumab Vedotin Superior to Chemotherapy in Urothelial Cancer

Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA

Low-Dose Capecitabine Maintenance Therapy Improves Survival in Patients with Triple-Negative Breast Cancer

Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA

FDA Updates

Yescarta First CAR T-Cell Therapy Approved for Follicular Lymphoma

Libtayo Receives 2 New Indications: For Basal-Cell Carcinoma and for NSCLC

Abecma First CAR T-Cell Therapy Approved for Multiple Myeloma

Meeting Highlights

Atezolizumab, Vemurafenib, and Cobimetinib Triplet Therapy Improves PFS in BRAF-Positive Melanoma

Two Ways to Target Tumors with KRAS Mutations

Targeted Therapy with Olaparib Beneficial in Metastatic Prostate Cancer with Gene Mutations

Ceritinib Effective in Treating Brain Metastases in NSCLC

Paradigm Shift: PARP Inhibitors Should Be Offered to All Patients with Ovarian Cancer

Adding CDK4/6 Inhibitor to Endocrine Therapy Improves Survival in Advanced Breast Cancer: New Standard of Care